top of page

Verve's Sek Kathiresan on 2023 progress and working to bring base editing for LDL lowering to market

Sek Kathiresan discusses Verve's first-in-human data, getting an IND cleared in the United States, and the company's partnership with Eli Lilly.

Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page